Earnings & Reporting

Folding bike leader DAHON TECH posts record profits, driven not just by sales, but by a deep strategy of proprietary patents, AI manufacturing, and ecosystem building.

A new industry benchmark reveals interactive 3D tools are no longer a novelty but a core driver of revenue, with consumers spending 20 minutes planning.

As revenues fall, Chinese social e-commerce platform Yunji is cutting costs and culling partners. Is this a sign of distress or a savvy pivot to a more loyal, profitable future?

Telix's impressive H1 results show more than just profit; they reveal a calculated strategy to build a global radiopharmaceutical powerhouse.

MEXC's latest audit reveals a staggering 288% Bitcoin reserve, setting a high bar for transparency. But as it builds a financial fortress, user complaints raise a critical question: is on-chain proof enough?

Multitude Capital's H1 report shows declining profits but a €70M funding coup. We unpack the strategic genius behind fueling a FinTech empire.

Bigbank's record loan and deposit growth paints a picture of success, but soaring operational costs reveal a strategic gamble on future dominance. Is the price too high?

Swedish rugged tech firm JLT Mobile Computers posts grim financials, citing AI-driven costs. But a deeper look reveals a strategic pivot to new markets.

With improving financials and a key capital raise, Eco Wave Power isn't just surviving; it's strategically pivoting to power the AI industry's voracious energy needs.

Amid tenant shifts and market headwinds, EfTEN Real Estate Fund's July NAV growth reveals a story of strategic agility and financial acumen in a complex market.

Beyond the record revenue, Applied BioCode's growth reveals a strategy of solving lab bottlenecks and securing reimbursement, positioning it against industry giants.

Hyosung’s impressive H1 2026 results reveal a shrewd strategy: localizing US power grid production for the AI boom while betting on bio-textiles and humanists.

Lithuania's grid operator swung from a €42M loss to a €39M profit. Beyond the numbers lies a story of regulatory finesse and strategic investment fueling energy independence.

As Ascentage Pharma preps its mid-year report, we look beyond the balance sheet at the strategic plays and clinical trials fueling its global oncology ambitions.

Zinzino's 20% sales jump masks a complex global story. While it conquers the Americas, its European home turf is faltering. What does this reveal?

Facing revenue headwinds from currency shifts and regulatory hurdles, China's Jin Medical doubles down on R&D and operational efficiency. A look inside their strategy.

While global industrial markets waver, refractory leader RHI Magnesita proves strategic self-help can deliver powerful growth. Here's how they're doing it.

With a 14.5% profit surge, Renault's finance arm proves its resilience, driving EV adoption and redefining ownership in a volatile automotive market.

As enterprises face spiraling tech complexity, Tangoe's record growth and AI tools reveal a market desperate for control, savings, and actionable intelligence.